When Medicines Interact
Reviewed by Dr C. J. Odike, MRCGP · July 2026
Medicines do not interact simply because they are taken together. A second substance may change how much medicine reaches the body or may add to its effects. The exact products, doses, timing and individual risk determine whether action is needed.
What a medicine interaction means A medicine interaction occurs when another medicine, food, drink or complementary product changes a medicine's effect. The change may increase harm, reduce benefit or occasionally produce a useful combined effect. Taking two medicines together does not automatically create a clinically important interaction. Significance depends on the exact substances, doses, routes, timing, treatment aims and individual person. Interactions are commonly grouped as pharmacokinetic or pharmacodynamic. Some combinations involve more than one mechanism. Pharmacokinetic interactions change exposure A pharmacokinetic interaction changes absorption, distribution, metabolism or excretion. It therefore changes how much active medicine reaches relevant sites or how long exposure lasts. One product may bind another inside the gut and reduce absorption. Separating the doses can help in selected interactions that occur through direct contact in the digestive system. Timing does not solve every interaction. It usually cannot prevent an additive effect or an interaction caused by longer lasting enzyme changes. Enzyme inhibition and induction work differently Enzymes help metabolise many medicines. Enzyme inhibition reduces an enzyme's activity and often raises the level of a medicine processed by it. Enzyme induction increases enzyme activity and often lowers the level of a medicine processed by it. Induction usually develops and resolves more slowly than many inhibition interactions. The direction can differ for a prodrug that needs metabolism to become active. Inhibition may reduce its activation, while induction may increase it. Transport proteins can also change absorption or removal. Interaction guidance therefore needs to consider the particular medicine rather than applying one liver rule to every product. Starting or stopping an inhibitor or inducer can change exposure. A medicine may need review even when the interacting product is being discontinued. Pharmacodynamic interactions change combined effects A pharmacodynamic interaction occurs when substances have additive, opposing or otherwise linked effects without necessarily changing each other's blood levels. An anticoagulant and a non steroidal anti inflammatory drug can increase bleeding risk through their combined effects. Some combinations of sedating medicines can increase drowsiness. Certain combinations can also suppress breathing. Some pharmacodynamic interactions are intentional. Clinicians may combine medicines that lower blood pressure through different mechanisms when the expected benefit outweighs the added risk. Food and drink interactions are medicine specific Food may change absorption or make a medicine easier to tolerate. Instructions to take a medicine with food or on an empty stomach therefore have different purposes. Grapefruit can affect enzymes and transport proteins in the small intestine. It raises exposure to some medicines but can reduce absorption of others. Grapefruit does not interact with every medicine. The leaflet or a pharmacist can confirm whether grapefruit, another fruit or a particular drink matters. Tobacco smoke can increase the activity of some metabolising enzymes. Starting, reducing or stopping smoking may therefore change exposure to selected medicines. Supplements and herbal products also need checking A complementary product includes herbal remedies, vitamins, minerals and other supplements used alongside conventional healthcare. Natural does not mean interaction free. Some interactions are well established. St John's wort can lower the effect of several important medicines by increasing enzyme and transporter activity. Evidence for many other products is limited, and ingredients or strengths may vary. This does not mean every supplement interacts as strongly as a prescription medicine. The safest approach is to provide the exact product name, ingredients and dose. A vague description such as joint supplement may not identify the relevant substance. Polypharmacy can be appropriate or problematic Polypharmacy means using multiple medicines. It may be appropriate when each medicine has a clear purpose and the combination is regularly reviewed. More medicines create more possible combinations, but the number alone does not determine risk. Particular high risk medicines, frailty, organ impairment and unclear treatment need may matter more. A structured medication review checks for interactions, duplication, unnecessary treatment, monitoring needs and practical burden. The aim is not simply to reduce the medicine count. How clinicians check interaction risk Medicines reconciliation creates an accurate list of prescribed medicines, over the counter medicines and complementary products. It should include recent medicines, occasional products and anything recently stopped. The clinician or pharmacist checks authoritative interaction resources and the official product information. No single interaction checker contains every possible combination or replaces clinical interpretation. They assess the mechanism, expected size and timing of the interaction. They also consider the indication, alternatives, kidney or liver function, previous reactions and the consequences of reduced treatment effect. A warning may lead to avoiding the combination, changing one medicine, adjusting a dose, separating doses or arranging monitoring. Some combinations need no change after individual assessment. Monitoring depends on the exact medicine There is no universal interaction blood test. Monitoring may involve symptoms, blood pressure, an ECG, kidney or liver tests, a medicine concentration or another medicine specific measure. Warfarin is monitored using the international normalised ratio, or INR. Direct oral anticoagulants do not use routine INR monitoring, even though they also have important interactions. A normal test does not exclude every interaction. Monitoring answers defined questions and must be combined with the person's symptoms and treatment response. What you should do Tell the prescriber and pharmacist about every prescribed medicine, over the counter medicine, vitamin, mineral, herbal product and recreational substance you use. Include products taken only occasionally. Check before starting or stopping a supplement, over the counter medicine or regular food product that may interact. Do not stop a prescribed medicine suddenly unless emergency instructions specifically tell you to do so. Call 999 for severe breathing difficulty, a seizure, collapse, unresponsiveness or bleeding that will not stop. Urgent assessment is also needed for vomiting blood, coughing blood, black stools or a sudden severe headache while taking an anticoagulant. For less severe new symptoms or suspected interactions, contact a pharmacist, prescriber, anticoagulant service or NHS 111 as appropriate. This lesson explains general interaction principles. It cannot determine whether a particular combination is safe for an individual person.
Medicine interactions can change exposure or combined effects. Their clinical importance depends on the exact products and person, so a complete medicine list and medicine specific assessment matter more than broad rules.
Medical words made simple
- Medicine interaction
- A change in a medicine's effect caused by another medicine, food, drink or complementary product. The change may increase harm, reduce benefit or be useful.
- Pharmacokinetic interaction
- An interaction that changes absorption, distribution, metabolism or excretion and therefore changes medicine exposure.
- Pharmacodynamic interaction
- An interaction where substances have additive, opposing or linked effects without necessarily changing each other's blood levels.
- Enzyme inhibition
- Reduced activity of a metabolising enzyme. This often raises the level of a medicine processed by that enzyme, although prodrugs can behave differently.
- Enzyme induction
- Increased activity of a metabolising enzyme. This often lowers the level of a medicine processed by that enzyme and may develop gradually.
- Over-the-counter medicine
- A medicine bought without a prescription. It can still cause side effects and interact with prescribed treatment.
- Complementary product
- A herbal remedy, vitamin, mineral or other supplement used alongside conventional healthcare. Evidence and interaction risk vary between products.
- Polypharmacy
- The use of multiple medicines. It may be appropriate, but the benefits, interactions and treatment burden should be reviewed.
- Medicines reconciliation
- Creating and checking an accurate list of everything a person uses, including prescribed, occasional, over-the-counter and complementary products.
- INR
- A standardised result from a blood clotting test used to guide warfarin treatment. It does not provide routine monitoring for every anticoagulant.
Quick recap
- Medicine interactions may change exposure, add or oppose effects, reduce treatment benefit or sometimes create a useful combination.
- Pharmacokinetic interactions affect absorption, distribution, metabolism or excretion, while pharmacodynamic interactions alter combined effects.
- Enzyme inhibition often raises medicine levels and enzyme induction often lowers them, although prodrugs can behave differently.
- Dose separation helps selected gut absorption interactions but does not solve every enzyme based or additive interaction.
- Over the counter medicines, food, smoking and complementary products can matter, but their risks must be assessed product by product.
- Polypharmacy is not automatically inappropriate, and interaction alerts require clinical interpretation, accurate records and medicine specific management.